Please assess the completion status of the following clinical trial:

Trial Title: A Study of E7080 in Subjects With Advanced Thyroid Cancer

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria~1. Histologically or clinically diagnosed with thyroid cancer~2. Eastern Cooperative Oncology Group Performance Status (ECOG-PS) 0-2~3. Adequate laboratory values/organ function tests~Exclusion criteria~Participants with following complication or disease history~1. Brain metastasis~2. Systemic severe infection~3. Significant cardiovascular impairment~4. QTc greater than 480 milliseconds~5. Active hemoptysis~6. Bleeding or thrombotic disorders~7. Having greater than 1+ proteinuria on urine dipstick testing will undergo 24 hour urine collection for quantitative assessment of proteinuria~8. Gastrointestinal malabsorption or any other condition in the opinion of the investigator that might affect the absorption of E7080~9. Major surgery within 3 weeks before enrollment~10. With co-existing effusion requiring drainage

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- E7080 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).